Clinical outcome measures of psoriasis
| Autor: | Enzo Berardesca, Claudio Bonifati |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
lcsh:Internal medicine
medicine.medical_specialty lcsh:Medicine Arthritis macromolecular substances Severity of Illness Index Psoriatic arthritis Rheumatology Quality of life Psoriasis Internal medicine Severity of illness Outcome Assessment Health Care medicine Humans lcsh:RC31-1245 Physical Examination Societies Medical Clinical Trials as Topic business.industry lcsh:R Arthritis Psoriatic Dermatology Life Quality Index medicine.disease Prognosis Dermatology United States Clinical trial Treatment Outcome Italy Research Design Quality of Life business |
| Zdroj: | Reumatismo, Vol 59, Iss 1s, Pp 64-67 (2011) |
| ISSN: | 0048-7449 |
| Popis: | Several tools have been introduced in clinical trials to quantify the severity and the response to a given therapeutic regimen of both psoriasis and psoriatic arthritis. Each method present specific advantages and limitations. Here we will discuss some of the most popular clinical outcome measures of both psoriasis (Psoriasis Severity Index, Physician Global Assessment, National Psoriasis Fundation-Psoriasis Score, Dermatology Life Quality Index) and psoriatic arthritis (American College Rheumatology response criteria, Psoriatic Arthritis Response Criteria). Key words: Psoriasis, psoriatic arthritis, outcome |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|